Login / Signup

Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.

Narayan PrasadJithu KurianVikas AgarwalDharmendra BhadauriaManas BeheraMonika YachaRavi KushwahaVinita AgrawalManoj JainAmit Gupta
Published in: Lupus (2020)
Long-term outcomes in terms of patient and renal survival of LN patients treated with CYP and MMF induction are similar. Doubling of serum creatinine occurred more with AZA-based maintenance therapy than with MMF-based maintenance therapy. Most deaths occurred during induction, and sepsis was the most common cause of death.
Keyphrases
  • intensive care unit
  • low dose
  • acute kidney injury
  • case report
  • uric acid
  • bone marrow
  • septic shock